Position in GPCR
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$10,262,695
-$3,819,579 QoQ
Shares Held
212,919
+5.2% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Derivatives in GPCR
reported options exposure · as of Dec 31, 2025CallValue
$27,820
CallShares
400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. GPCR ranks #103 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in GPCR
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,262,695 | 212,919 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $27,820 | 400 | Call | Defined | 2026-01-29 | |
| 2025-12-31 | $14,082,274 | 202,477 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $5,826,576 | 208,092 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $590,800 | 21,100 | Call | Defined | 2025-11-13 | |
| 2025-06-30 | $3,172,825 | 152,981 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $647,088 | 31,200 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $4,123,189 | 238,197 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $154,059 | 8,900 | Call | Defined | 2025-05-13 | |
| 2024-12-31 | $6,618,987 | 244,063 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $984,456 | 36,300 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $1,715,220 | 39,080 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $210,604 | 5,363 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,545,121 | 82,714 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,430,804 | 59,637 | Shares | Sole | 2024-02-09 | |
| 2023-06-30 | $83 | 2 | Shares | Sole | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||